The health minister’s announced that Orkambi and Kalydeco will be provided for cystic fibrosis patients from next month.
The Health Service Executive and manufacturers Vertex have reached agreement in principle – it now just needs to be signed off by lawyers on both sides.
The deal will also see other drugs for other ages of those with CF once authorised in Europe.
- Advertisement -
The announcement has been warmly welcomed by Cystic Fibrosis Ireland.
Chief Executive Philip Watt says 600 CF patients have the potential to benefit from the new drugs.
